Dr. Nancy J Bunin, MD
Claim this profileChildren's Hospital of Philadelphia
Studies Primary Immunodeficiency
Studies Leukemia
15 reported clinical trials
18 drugs studied
Area of expertise
1Primary Immunodeficiency
IgG to EBV positive
T-cell response to BZLF-1 positive
T-cell response to NA-1 positive
2Leukemia
HLA negative
CD3 positive
CD3 negative
Affiliated Hospitals
Clinical Trials Nancy J Bunin, MD is currently running
Tabelecleucel
for Post-Transplant Cancer
The purpose of this study is to determine the clinical benefit and characterize the safety profile of tabelecleucel for the treatment of Epstein-Barr virus-associated post-transplant lymphoproliferative disease (EBV+ PTLD) in the setting of (1) solid organ transplant (SOT) after failure of rituximab (SOT-R) and rituximab plus chemotherapy (SOT-R+C) or (2) allogeneic hematopoietic cell transplant (HCT) after failure of rituximab.
Recruiting2 awards Phase 312 criteria
SARS-CoV-2 CTLS
for COVID-19
The 2019 Severe Acute Respiratory Syndrome (SARS) is a global pandemic secondary to a novel coronavirus - SARS-CoV-2. The reported case-fatality ratio for SARS-CoV-2 in the United States is 1.8% with a current death toll of \>300,000 and climbing.4 There is no accepted standard of care or FDA approved therapies for treatment of COVID-19. Virus specific cytotoxic T lymphocytes (CTLs) have become an important part of the treatment landscape for viral reactivation post hematopoietic and solid organ transplantation. Donor derived CTLs have been shown to be safe and effective against a variety of viruses including CMV, EBV, BK and adenovirus. We hypothesize that SARS-CoV-2 specific CTLs generated from a previously infected family donor will be safe and effective for treatment of COVID-19 in family members with mild to moderate disease.
Recruiting1 award Phase 1 & 26 criteria
More about Nancy J Bunin, MD
Clinical Trial Related7 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 11 Active Clinical TrialsTreatments Nancy J Bunin, MD has experience with
- Busulfan
- BK CTL
- Viral Specific Cytotoxic T-Lymphocytes
- Adenovirus-specific Cytotoxic T-lymphocytes
- Cytotoxic T-lymphocytes
- Tabelecleucel
Breakdown of trials Nancy J Bunin, MD has run
Primary Immunodeficiency
Leukemia
Epstein-Barr Virus Infection
Thalassemia
Bone Marrow Failure Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nancy J Bunin, MD specialize in?
Nancy J Bunin, MD focuses on Primary Immunodeficiency and Leukemia. In particular, much of their work with Primary Immunodeficiency has involved IgG to EBV positive patients, or patients who are T-cell response to BZLF-1 positive.
Is Nancy J Bunin, MD currently recruiting for clinical trials?
Yes, Nancy J Bunin, MD is currently recruiting for 11 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Nancy J Bunin, MD has studied deeply?
Yes, Nancy J Bunin, MD has studied treatments such as Busulfan, BK CTL, Viral Specific Cytotoxic T-Lymphocytes.
What is the best way to schedule an appointment with Nancy J Bunin, MD?
Apply for one of the trials that Nancy J Bunin, MD is conducting.
What is the office address of Nancy J Bunin, MD?
The office of Nancy J Bunin, MD is located at: Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104 United States. This is the address for their practice at the Children's Hospital of Philadelphia.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.